Antibody-dependent cell-mediated cytotoxicity- and complement-dependent cytotoxicity-independent bactericidal activity of an IgG against Pseudomonas aeruginosa O6ad

Journal of Immunology

Volumn 184, Issue 7, 2010, Pages 3725-3733

  Xie, Xuemei ^a,b   McLean, Michael D ^a   Hall, J Christopher ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; BACTERIUM ANTIBODY; FV PROTEIN, HUMAN; LYMPHOKINE; SIALOGLYCOPROTEIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL DIVISION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS AGALACTIAE; ANIMAL; COMPLEMENT ACTIVATION; GENETICS; IMMUNOLOGY; SCANNING ELECTRON MICROSCOPY; TOBACCO; TRANSGENIC PLANT; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; COMPLEMENT ACTIVATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; LYMPHOKINES; MICE; MICROSCOPY, ELECTRON, SCANNING; PLANTS, GENETICALLY MODIFIED; PSEUDOMONAS AERUGINOSA; SIALOGLYCOPROTEINS; TOBACCO;

EID: 77951647830     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902732     Document Type: Article

References (75)

1. Burton, D. R. 1990. Antibody: the flexible adaptor molecule. Trends Biochem. Sci. 15: 64-69.
2. Osborne, B. A., T. J. Kindt, J. Kuby, and R. A. Goldsby. 2006. Immunology. W. H. Freeman & Co., New York.
3. Fiori, P. L., A. Mattana, D. Dessì, S. Conti, W. Magliani, and L. Polonelli. 2006. In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide. J. Antimicrob. Chemother. 57: 891-898.
4. Fitzgerald, S. P., and H. J. Rogers. 1980. Bacteriostatic effect of serum: role of antibody to lipopolysaccharide. Infect. Immun. 27: 302-308.
5. Moragues, M. D., M. J. Omaetxebarria, N. Elguezabal, M. J. Sevilla, S. Conti, L. Polonelli, and J. Pontón. 2003. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect. Immun. 71: 5273-5279.
6. Pollack, S. J., J. W. Jacobs, and P. G. Schultz. 1986. Selective chemical catalysis by an antibody. Science 234: 1570-1573.
7. Tramontano, A., K. D. Janda, and R. A. Lerner. 1986. Catalytic antibodies. Science 234: 1566-1570.
8. Baranovskii, A. G., N. A. Ershova, V. N. Buneva, T. G. Kanyshkova, A. S. Mogelnitskii, B. M. Doronin, A. N. Boiko, E. I. Gusev, O. O. Favorova, and G. A. Nevinsky. 2001. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol. Lett. 76: 163-167.
9. Nishiyama, Y., S. Karle, S. Planque, H. Taguchi, and S. Paul. 2007. Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunit. Mol. Immunol. 44: 2707-2718.
10. Parkhomenko, T. A., E. S. Odintsova, V. N. Buneva, E. V. Kunder, I. V. Zhyltsov, S. A. Senkovich, I. I. Generalov, and G. A. Nevinsky. 2009. DNA-hydrolyzing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections. J. Cell. Mol. Med. 13: 2875-2887.
11. Saveliev, A. N., D. R. Ivanen, A. A. Kulminskaya, N. A. Ershova, T. G. Kanyshkova, V. N. Buneva, A. S. Mogelnitskii, B. M. Doronin, O. O. Favorova, G. A. Nevinsky, and K. N. Neustroev. 2003. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol. Lett. 86: 291-297.
12. Wang, Y., B. Qiao, Y. Wang, X. Han, Y. Chu, and S. Xiong. 2006. Autoantibodies closely relate to the elevation level of in vivo hydrogen peroxide and tissue damage in systemic lupus erythematosus. DNA Cell Biol. 25: 563-570. (Pubitemid 46150667)
13. Wentworth, P., Jr., L. H. Jones, A. D. Wentworth, X. Zhu, N. A. Larsen, I. A. Wilson, X. Xu, W. A. Goddard, 3rd, K. D. Janda, A. Eschenmoser, and R. A. Lerner. 2001. Antibody catalysis of the oxidation of water. Science 293: 1806-1811.
14. Wentworth, P., Jr., J. E. McDunn, A. D. Wentworth, C. Takeuchi, J. Nieva, T. Jones, C. Bautista, J. M. Ruedi, A. Gutierrez, K. D. Janda, et al. 2002. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 298: 2195-2199.
15. Wentworth, P., Jr., A. D. Wentworth, X. Zhu, I. A. Wilson, K. D. Janda, A. Eschenmoser, and R. A. Lerner. 2003. Evidence for the production of trioxygen species during antibody- catalyzed chemical modification of antigens. Proc. Natl. Acad. Sci. USA 100: 1490-1493.
16. Wentworth, A. D., L. H. Jones, P. Wentworth, Jr., K. D. Janda, and R. A. Lerner. 2000. Antibodies have the intrinsic capacity to destroy antigens. Proc. Natl. Acad. Sci. USA 97: 10930-10935.
17. Datta, D., N. Vaidehi, X. Xu, and W. A. Goddard, 3rd. 2002. Mechanism for antibody catalysis of the oxidation of water by singlet dioxygen. Proc. Natl. Acad. Sci. USA 99: 2636-2641.
18. Xu, X., R. P. Muller, and W. A. Goddard, 3rd. 2002. The gas phase reaction of singlet dioxygen with water: a water-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 99: 3376-3381.
19. Babior, B. M., C. Takeuchi, J. Ruedi, A. Gutierrez, and P. Wentworth, Jr. 2003. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. USA 100: 3031-3034.
20. Lerner, R. A., and A. Eschenmoser. 2003. Ozone in biology. Proc. Natl. Acad. Sci. USA 100: 3013-3015.
21. Rogers, H. J. 1976. Ferric iron and the antibacterial effects of horse 7S antibodies to Escherichia coli O111. Immunology 30: 425-433.
22. Rogers, H. J., and C. Synge. 1978. Bacteriostatic effect of human milk on Escherichia coli: the role of IgA. Immunology 34: 19-28.
23. Goel, V. K., and A. Kapil. 2001. Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal. BMC Microbiol. 1: 16.
24. Coleman, J. L., R. C. Rogers, and J. L. Benach. 1992. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB. Infect. Immun. 60: 3098-3104.
25. Sadziene, A., P. A. Thompson, and A. G. Barbour. 1993. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J. Infect. Dis. 167: 165-172.
26. Sadziene, A., M. Jonsson, S. Bergström, R. K. Bright, R. C. Kennedy, and A. G. Barbour. 1994. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect. Immun. 62: 2037-2045.
27. Becker, M., J. Bunikis, B. D. Lade, J. J. Dunn, A. G. Barbour, and C. L. Lawson. 2005. Structural investigation of Borrelia burgdorferi OspB, a bactericidal Fab target. J. Biol. Chem. 280: 17363-17370.
28. Escudero, R., M. L. Halluska, P. B. Backenson, J. L. Coleman, and J. L. Benach. 1997. Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy. Infect. Immun. 65: 1908-1915.
29. Connolly, S. E., D. G. Thanassi, and J. L. Benach. 2004. Generation of a complement- independent bactericidal IgM against a relapsing fever Borrelia. J. Immunol. 172: 1191-1197.
30. LaRocca, T. J., L. I. Katona, D. G. Thanassi, and J. L. Benach. 2008. Bactericidal action of a complement-independent antibody against relapsing fever Borrelia resides in its variable region. J. Immunol. 180: 6222-6228.
31. Nasirudeen, A. M., and K. S. Tan. 2004. Caspase-3-like protease influences but is not essential for DNA fragmentation in Blastocystis undergoing apoptosis. Eur. J. Cell Biol. 83: 477-482.
32. Tan, S. W., M. Singh, L. C. Ho, J. Howe, K. T. Moe, X. Q. Chen, G. C. Ng, and E. H. Yap. 1997. Survival of Blastocystis hominis clones after exposure to a cytotoxic monoclonal antibody. Int. J. Parasitol. 27: 947-954.
33. Tan, K. S., M. Ibrahim, G. C. Ng, A. M. Nasirudeen, L. C. Ho, E. H. Yap, and M. Singh. 2001. Exposure of Blastocystis species to a cytotoxic monoclonal antibody. Parasitol. Res. 87: 534-538.
34. Sevilla, M. J., B. Robledo, A. Rementeria, M. D. Moragues, and J. Pontón. 2006. A fungicidal monoclonal antibody protects against murine invasive candidiasis. Infect. Immun. 74: 3042-3045.
35. Conti, S., F. Fanti, W. Magliani, M. Gerloni, D. Bertolotti, A. Salati, A. Cassone, and L. Polonelli. 1998. Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies. J. Infect. Dis. 177: 807-811.
36. Cenci, E., A. Mencacci, A. Spreca, C. Montagnoli, A. Bacci, K. Perruccio, A. Velardi, W. Magliani, S. Conti, L. Polonelli, and L. Romani. 2002. Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation. Infect. Immun. 70: 2375-2382.
37. Polonelli, L., F. De Bernadis, S. Conti, M. Boccanera, W. Magliani, M. Gerloni, C. Cantelli, and A. Cassone. 1996. Human natural yeast killer toxin-like candidacidal antibodies. J. Immunol. 156: 1880-1885. (Pubitemid 26072556)
38. Magliani, W., S. Conti, L. R. Travassos, and L. Polonelli. 2008. From yeast killer toxins to antibiobodies and beyond. FEMS Microbiol. Lett. 288: 1-8.
39. Magliani, W., S. Conti, F. de Bernardis, M. Gerloni, D. Bertolotti, P. Mozzoni, A. Cassone, and L. Polonelli. 1997. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15: 155-158.
40. McLean, M. D., K. C. Almquist, Y. Niu, R. Kimmel, Z. Lai, J. R. Schreiber, and J. C. Hall. 2007. A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro. Antimicrob. Agents Chemother. 51: 3322-3328.
41. Yi, E. C., and M. Hackett. 2000. Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria. Analyst 125: 651-656.
42. Palczewska, M., P. Groves, and J. Kuznicki. 1999. Use of Pichia pastoris for the expression, purification, and characterization of rat calretinin "EF-hand" domains. Protein Expr. Purif. 17: 465-476.
43. Weisser, N. E., K. C. Almquist, and J. C. Hall. 2007. A rAb screening method for improving the probability of identifying peptide mimotopes of carbohydrate antigens. Vaccine 25: 4611-4622.
44. Palczewska, M., G. Batta, and P. Groves. 2003. Concanavalin A-agarose removes mannan impurities from an extracellularly expressed Pichia pastoris recombinant protein. Cell. Mol. Biol. Lett. 8: 783-792.
45. Sun, M., L. Li, Q. S. Gao, and S. Paul. 1994. Antigen recognition by an antibody light chain. J. Biol. Chem. 269: 734-738.
46. Hemachandra, S., K. Kamboj, J. Copfer, G. Pier, L. L. Green, and J. R. Schreiber. 2001. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Infect. Immun. 69: 2223-2229.
47. Pier, G. B., D. Thomas, G. Small, A. Siadak, and H. Zweerink. 1989. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide. Infect. Immun. 57: 174-179.
48. Schreiber, J. R., K. L. Nixon, M. F. Tosi, G. B. Pier, and M. B. Patawaran. 1991. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies. J. Immunol. 146: 188-193.
49. Papo, N., and Y. Shai. 2003. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides 24: 1693-1703.
50. Papo, N., and Y. Shai. 2005. A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides. J. Biol. Chem. 280: 10378-10387.
51. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462: 55-70.
52. Hancock, R. E. 1984. Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38: 237-264.
53. Buneva, V. N., T. G. Kanyshkova, A. V. Vlassov, D. V. Semenov, Khlimankov D Yu, L. R. Breusova, and G. A. Nevinsky. 1998. Catalytic DNA- and RNA-hydrolyzing antibodies from milk of healthy human mothers. Appl. Biochem. Biotechnol. 75: 63-76.
54. Kozyr, A. V., A. V. Kolesnikov, E. S. Aleksandrova, L. P. Sashchenko, N. V. Gnuchev, P. V. Favorov, M. A. Kotelnikov, E. I. Iakhnina, I. A. Astsaturov, T. B. Prokaeva, et al. 1998. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl. Biochem. Biotechnol. 75: 45-61.
55. Kozyr, A. V., L. P. Sashchenko, A. V. Kolesnikov, N. A. Zelenova, S. V. Khaidukov, A. N. Ignatova, T. V. Bobik, A. G. Gabibov, Z. S. Alekberova, S. V. Suchkov, and N. V. Gnuchev. 2002. Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol. Lett. 80: 41-47.
56. Lee, E. J., E. J. Jang, E. Lee, J. Yu, H. Y. Chung, and Y. J. Jang. 2007. Cell-penetrating autoantibody induces caspase-mediated apoptosis through catalytic hydrolysis of DNA. Bioorg. Med. Chem. 15: 2016-2023.
57. Nevinsky, G. A., T. G. Kanyshkova, D. V. Semenov, A. V. Vlassov, A. V. Gal'vita, and V. N. Buneva. 2000. Secretory immunoglobulin A from healthy human mothers' milk catalyzes nucleic acid hydrolysis. Appl. Biochem. Biotechnol. 83: 115-129; discussion 129-130, 145-153.
58. Ponomarenko, N. A., O. M. Durova, I. I. Vorobiev, A. A. Belogurov, Jr., I. N. Kurkova, A. G. Petrenko, G. B. Telegin, S. V. Suchkov, S. L. Kiselev, M. A. Lagarkova, et al. 2006. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc. Natl. Acad. Sci. U.S.A. 103: 281-286.
59. Semenov, D. V., T. G. Kanyshkova, Y. Y. Kit, D. Y. Khlimankov, A. M. Akimzhanov, D. A. Gorbunov, V. N. Buneva, and G. A. Nevinsky. 1998. Human breast milk immunoglobulins G hydrolyze nucleotides. Biochemistry (Mosc.) 63: 935-943. (Pubitemid 128588095)
60. Ivanen, D. R., A. A. Kulminskaya, N. A. Ershova, E. V. Eneyskaya, K. A. Shabalin, A. N. Savel'ev, T. G. Kanyshkova, V. N. Buneva, G. A. Nvinsky, and K. N. Neusstroev. 2002. Human autoantibodies with amylolytic activity. Biologia, Bratislava 57(Suppl. 11): 253-260.
61. Ivanen, D. R., A. A. Kulminskaya, K. A. Shabalin, L. V. Isaeva-Ivanova, N. A. Ershova, A. N. Saveliev, G. A. Nevinsky, and K. N. Neustroev. 2004. Catalyticproperties of IgMs with amylolytic activity isolated from patients with multiple sclerosis.Med. Sci. Monit. 10: BR273-BR280.
62. Savel'ev, A. N., T. G. Kanyshkova, A. A. Kulminskaya, V. N. Buneva, E. V. Eneyskaya, M. V. Filatov, G. A. Nevinsky, and K. N. Neustroev. 2001. Amylolytic activity of IgG and sIgA immunoglobulins from human milk. Clin. Chim. Acta 314: 141-152.
63. Stanislavsky, E. S., and J. S. Lam. 1997. Pseudomonas aeruginosa antigens as potential vaccines. FEMS Microbiol. Rev. 21: 243-277.
64. Alexander, C., and E. T. Rietschel. 2001. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7: 167-202.
65. Nikaido, H. 1989. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemother. 33: 1831-1836.
66. Rocchetta, H. L., L. L. Burrows, and J. S. Lam. 1999. Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 63: 523-553.
67. Ellison, R. T., III, T. J. Giehl, and F. M. LaForce. 1988. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56: 2774-2781.
68. Bechinger, B. 1999. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochim. Biophys. Acta 1462: 157-183.
69. Oren, Z., and Y. Shai. 1998. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47: 451-463. (Pubitemid 128637353)
70. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66: 236-248. (Pubitemid 36098316)
71. Shai, Y., and Z. Oren. 2001. From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22: 1629-1641.
72. Kim, J., C. L. Bronson, M. A. Wani, T. M. Oberyszyn, S. Mohanty, C. Chaudhury, W. L. Hayton, J. M. Robinson, and C. L. Anderson. 2008. Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice. Exp. Biol. Med. (Maywood) 233: 603-609.
73. Mozdzanowska, K., J. Feng, and W. Gerhard. 2003. Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice. J. Virol. 77: 8322-8328. (Pubitemid 36871460)
74. Huston, J. S., A. J. George, G. P. Adams, W. F. Stafford, F. Jamar, M. S. Tai, J. E. McCartney, H. Oppermann, B. T. Heelan, A. M. Peters, et al. 1996. Single-chain Fv radioimmunotargeting. Q. J. Nucl. Med. 40: 320-333.
75. Krinner, E. M., J. Hepp, P. Hoffmann, S. Bruckmaier, L. Petersen, S. Petsch, L. Parr, I. Schuster, S. Mangold, G. Lorenczewski, et al. 2006. A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration. Protein Eng. Des. Sel. 19: 461-470.